Clinical trial
Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)
NCT02660866 is registered in ClinicalTrials.gov with North Texas Veterans Healthcare System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)
- Lead sponsor
- North Texas Veterans Healthcare System
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- July 31, 2016
- Completion date
- July 31, 2019
- Enrollment
- 200 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.